NELL MILLING: Open Payments
NPI 1023693231 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,900 in 78 payments from 19 companies in 2025. Trend: 2023 $1,092 · 2024 $1,938 · 2025 $1,900
Food & beverage: $1,900
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $696 |
| Gilead Sciences, Inc. | 5 | $190 |
| Phathom Pharmaceuticals, Inc. | 1 | $126 |
| Regeneron Healthcare Solutions, Inc. | 4 | $122 |
| Madrigal Pharmaceuticals | 1 | $118 |
| Janssen Biotech, Inc. | 4 | $100 |
| Celltrion USA Inc. | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| PFIZER INC. | 4 | $77 |
| Ardelyx, Inc. | 4 | $62 |
Products named: RINVOQ, SKYRIZI, DUPIXENT, Epclusa, VOQUEZNA, CREON, REZDIFFRA, TREMFYA.
Industry payments across AL — which companies pay providers there.
